SEARCH

SEARCH BY CITATION

Bibliography

  • 1
    Feldman M & Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98: 37884.
  • 2
    Schvarcz E, Palmér M, Ingberg CM, Åman J & Berne C. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 1995; 13: 47881.
  • 3
    Enck P, Rathmann W & Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol 1994; 32: 63741.
  • 4
    Spångéus A, El-Salhy M, Suhr O, Eriksson J & Lithner F. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients. Scand J Gastroenterol 1999; 34: 1196202.
  • 5
    Ricci JA, Siddique R, Stewart WF, Sandler RS, Sloan S & Farup CE. Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. Scand J Gastroenterol 2000; 35: 1529.
  • 6
    Janatuinen E, Pikkarainen P, Laakso M & Pyörälä K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol 1993; 28: 42732.
  • 7
    Krentz AJ, Ferner RE & Bailey CJ. Comparative tolerability profiles of oral antidiabetic agents. Drug Safety 1994; 11: 22341.
  • 8
    Davidson MB & Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med 1997; 102: 99110.
  • 9
    Johansen K. Acarbose treatment of sulfonylurea-treated non-insulin dependent diabetics. A double-blind cross-over comparison of an alpha glucosidase inhibitor with metformin. Diabetes Metab 1984; 10: 21923.
  • 10
    Mayne N. Neuropathy in the diabetic and non-diabetic populations. Lancet 1965; 2: 13136.
  • 11
    Ko GT, Chan WB, Chan JC, Tsang LW & Cockram CS. Gastrointestinal symptoms in Chinese patients with type 2 diabetes mellitus. Diabet Med 1999; 16: 6704.
  • 12
    Phillips BB. Managing therapy and adverse effects with antihyperglycemic agents: a focus on metformin and acarbose. Pharm Pract Manag Q 1997; 17: 2131.
  • 13
    Dandona P, Fonseca V, Mier A & Beckett AG. Diarrhea and metformin in a diabetic clinic. Diabetes Care 1983; 6: 4724.
  • 14
    Lysy J, Israeli E & Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol 1999; 8: 216570.
    Direct Link:
  • 15
    World Health Organization Study Group. Prevention of Diabetes. Geneva: World Health Organization, 1994: 13.
  • 16
    Talley NJ, Phillips SF, Melton LJI, Wiltgen C & Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 6714.
  • 17
    Talley NJ, Boyce P, Owen BK, Newman P & Paterson K. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med 1995; 25: 3028.
  • 18
    Bytzer P, Talley NJ, Young LJ, Hammer J, Jones MP & Horowitz M. Gastrointestinal symptoms in diabetes mellitus are associated with diabetic complications and poor glycemic control. J Am Med Assoc, Submitted.
  • 19
    Haupt E, Knick B, Koschinsky T, Liebermeister H, Schneider J & Hirche H. Oral antidiabetic combination therapy with sulphonylureas and metformin. Diabetes Metab 1991; 17: 22431.
  • 20
    Clouse RE & Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 1989; 84: 86872.